These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. PSA evolution: a prognostic factor during treatment of advanced prostatic carcinoma with total androgen blockade. Data from a Belgian multicentric study of 546 patients. Oosterlinck W; Mattelaer J; Casselman J; Van Velthoven R; Derde MP; Kaufman L Acta Urol Belg; 1997 Oct; 65(3):63-71. PubMed ID: 9421938 [TBL] [Abstract][Full Text] [Related]
27. [Hormonal treatment in cancer of the prostate]. Boccon-Gibod L Rev Prat; 1987 Feb; 37(7):386-90. PubMed ID: 3823774 [No Abstract] [Full Text] [Related]
28. Androgen-deprivation therapy as primary treatment for localized prostate cancer: data from Cancer of the Prostate Strategic Urologic Research Endeavor (CaPSURE). Kawakami J; Cowan JE; Elkin EP; Latini DM; DuChane J; Carroll PR; Cancer; 2006 Apr; 106(8):1708-14. PubMed ID: 16544313 [TBL] [Abstract][Full Text] [Related]
32. Bicalutamide: a new antiandrogen for use in combination with castration for patients with advanced prostate cancer. Blackledge G; Kolvenbag G; Nash A Anticancer Drugs; 1996 Jan; 7(1):27-34. PubMed ID: 8742095 [TBL] [Abstract][Full Text] [Related]
33. Neoadjuvant hormonal deprivation in locally advanced prostate cancer: does it make sense? Schulman CC; Wildschutz TP Acta Urol Belg; 1996 May; 64(2):57-61. PubMed ID: 8701814 [No Abstract] [Full Text] [Related]
34. [New aspects of anti-androgenic therapy of prostatic cancer]. Portnoĭ AS Urol Nefrol (Mosk); 1985; (3):69-73. PubMed ID: 3892832 [No Abstract] [Full Text] [Related]
35. Is there a role for pure antiandrogens in the treatment of advanced prostatic cancer? Pavone-Macaluso M; Serretta V; Daricello G; Pavone C; Cacciatore M; Romano C; Cavallo N Prog Clin Biol Res; 1990; 350():149-57. PubMed ID: 2201041 [TBL] [Abstract][Full Text] [Related]
36. Hormonal treatment of prostate cancer. Smith S Ir Med J; 1996; 89(2):50. PubMed ID: 8682625 [No Abstract] [Full Text] [Related]
37. [First line therapy in the treatment of metastatic prostate cancer]. Sakai H; Kanetake H Gan To Kagaku Ryoho; 2003 Jan; 30(1):43-9. PubMed ID: 12557704 [TBL] [Abstract][Full Text] [Related]
38. Treating prostate cancer. Part V: androgen deprivation and chemotherapy. Harv Mens Health Watch; 1999 Dec; 4(5):5-8. PubMed ID: 10564905 [No Abstract] [Full Text] [Related]
39. [Maximal androgen blockade in the treatment of patients with disseminated cancer of the prostate]. Matveev BP; Bukharkin BV Vopr Onkol; 1998; 44(5):537-40. PubMed ID: 9884710 [TBL] [Abstract][Full Text] [Related]
40. Overview of hormonal therapy for prostate cancer. Carter HB; Isaacs JT Prog Clin Biol Res; 1990; 350():129-40. PubMed ID: 2201039 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]